Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC).
Renal cell carcinoma (RCC) is diagnosed in >200,000 individuals worldwide each year, accounting for ~2% of all cancers, but the spread of this disease amongst genders is distinctly uneven. In the U.S. the male:female incidence ratio is approximately 2:1. A potential hypothesis is mutation spectra...
Saved in:
| Main Authors: | Christopher J Ricketts, W Marston Linehan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0140257 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Endomucin Expression Correlates with a Favorable Immune Landscape and Improved Survival in Clear-Cell Renal Cell Carcinoma (ccRCC)
by: Abdulmalek Abu Zahra
Published: (2024-04-01) -
Writing History in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC): The Magic Goal of an Overall Survival Benefit Was Reached as Reported at ASCO GU 2024
by: Ursula Vogl
Published: (2024-03-01) -
Genetics and Tumor Microenvironment of Renal Cell Carcinoma
by: Sari Khaleel, et al.
Published: (2022-11-01) -
Gender-specific insights into TTN mutation: potential biomarker for female risk in kidney renal clear cell carcinoma
by: Ayan Saha, et al.
Published: (2025-09-01) -
Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)